MyMyelomaTeam

The survival rates after a stem cell transplant for multiple myeloma vary based on the type of transplant and individual response. For autologous transplants, the five-year survival rate is 94%, and the 10-year survival rate is 90%. For allogeneic transplants, the five-year survival rate is 59%, but it can be as high as 82% Show Full Answer

The survival rates after a stem cell transplant for multiple myeloma vary based on the type of transplant and individual response. For autologous transplants, the five-year survival rate is 94%, and the 10-year survival rate is 90%. For allogeneic transplants, the five-year survival rate is 59%, but it can be as high as 82% if the myeloma responded to a prior autologous transplant. Outcomes depend on factors like treatment response and overall health.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Allogeneic (donor) stem cell transplant for Myeloma | MyMyelomaTeam

Stem Cell Transplants for Multiple Myeloma: Your Guide | MyMyelomaTeam